As a circadian gene, CRY2's abnormal regulation leads to the disturbance of circadian rhythm, which can induce the development of cancers (like breast cancer) by affecting specific physiological functions such as signal transduction, cell division, and growth [46, 47]. This evidence concerns the gene CRY2 and breast cancer.